Protein
self-assembly plays an important role in biological
systems,
accounting for the formation of mesoscopic structures that can be
highly symmetric as in the capsid of viruses or disordered as in molecular
condensates or exhibit a one-dimensional fibrillar morphology as in
amyloid fibrils. Deposits of the latter in tissues of individuals
with degenerative diseases like Alzheimer’s and Parkinson’s
has motivated extensive efforts to understand the sequence of molecular
events accounting for their formation. These studies aim to identify
on-pathway intermediates that may be the targets for therapeutic intervention.
This detailed knowledge of fibril formation remains obscure, in part
due to challenges with experimental analyses of these processes. However,
important progress is being achieved for short amyloid peptides due
to advances in our ability to perform completely unbiased all-atom
simulations of the self-assembly process. This perspective discusses
recent developments, their implications, and the hurdles that still
need to be overcome to further advance the field.